Request Demo
Last update 23 May 2026
BMS-986172
Last update 23 May 2026
Overview
Basic Info
Drug Type Small molecule drug |
Synonyms BMS 986172, BMS-986172, BMS986172 |
Target |
Action inhibitors |
Mechanism MGAT2 inhibitors(alpha-1,6-mannosyl-glycoprotein 2-beta-N-acetylglucosaminyltransferase inhibitors) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
License Organization- |
Drug Highest PhasePendingPhase 1 |
First Approval Date- |
Regulation- |
Login to view timeline
Structure/Sequence
Molecular FormulaC24H22F7N7O3 |
InChIKeyVFFPVFKSCNJAMO-QFIPXVFZSA-N |
CAS Registry1808258-99-2 |
Related
1
Clinical Trials associated with BMS-986172NCT04926051
A Phase 1, Double-blind, Placebo-controlled, Randomized, Single and Multiple Ascending Dose, and a Japanese Multiple Ascending Dose Study to Evaluate the Safety, Tolerability and Pharmacokinetics of BMS-986172, Including an Open-Label Assessment of Relative Bioavailability and Food Effect on the Single-Dose Pharmacokinetics of BMS-986172 in Healthy and Obese Otherwise Healthy Participants
100 Clinical Results associated with BMS-986172
Login to view more data
100 Translational Medicine associated with BMS-986172
Login to view more data
100 Patents (Medical) associated with BMS-986172
Login to view more data
100 Deals associated with BMS-986172
Login to view more data
R&D Status
10 top R&D records. to view more data
Login
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Obesity | Phase 1 | United States | 15 Jun 2021 |
Login to view more data
Clinical Result
Clinical Result
Indication
Phase
Evaluation
View All Results
Login to view more data
Translational Medicine
Boost your research with our translational medicine data.
login
or
Deal
Boost your decision using our deal data.
login
or
Core Patent
Boost your research with our Core Patent data.
login
or
Clinical Trial
Identify the latest clinical trials across global registries.
login
or
Approval
Accelerate your research with the latest regulatory approval information.
login
or
Regulation
Understand key drug designations in just a few clicks with Synapse.
login
or
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free